---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-001482"
form_type: "8-K"
ticker: "VANI"
cik: "0001266806"
company_name: "Vivani Medical, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:14:20.038334+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vivani Medical Q3 net loss $6.8M; adds NPM-115 for weight management

## Summary
- Net loss of $6.8M in Q3 2023 vs net income of $1.4M in Q3 2022, driven by prior-year bargain purchase gain.
- Cash and equivalents $26.2M at Sept 30, 2023; expected to fund operations into early 2025.
- Announced NPM-115 (high-dose exenatide implant) for chronic weight management in obese/overweight patients.
- FDA clinical hold on NPM-119 FIH study due to CMC requests; also planning FIH study in Australia.
- R&D expense $4.4M (+15% YoY); G&A expense $2.7M (+71% YoY) due to merger-related costs.

## SEC filing metadata
- accession: 0001753926-23-001482
- form_type: 8-K
- ticker: VANI
- cik: 0001266806
- company_name: Vivani Medical, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1266806/000175392623001482/0001753926-23-001482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1266806/000175392623001482/g083854_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-001482
- JSON: https://secwatch.observer/filing/0001753926-23-001482.json
- Plain text: https://secwatch.observer/filing/0001753926-23-001482.txt

## Key facts
- Earnings Releases
  Vivani Medical, Inc. reported financial results for third quarter of 2023.
  - Period: third quarter of 2023
  - Result: reported results
  source text: today reported financial results for the third quarter of 2023 and provided a business update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1266806/000175392623001482/0001753926-23-001482-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.